<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang F</submitter><funding>S&amp;amp;T Program of Chengde</funding><funding>S&amp;T Program of Hebei</funding><funding>S&amp;T Program of Chengde</funding><funding>S&amp;amp;T Program of Hebei</funding><pagination>32</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9862514</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The carriers of damaging heterozygous variants in interferon regulatory factor 2 binding protein-like (IRF2BPL), encoding a member of the IRF2BP family of transcriptional regulators, may be affected by a variety of neurological symptoms, such as neurodevelopmental regression, language and motor developmental delay, seizures, progressive ataxia and a lack of coordination, and even dystonia.&lt;h4>Case presentation&lt;/h4>We report a Chinese boy who presented with dystonia, dysarthria, and normal development due to nonsense IRF2BPL mutation, with intact imaging and EEG findings but without developmental delays or seizures. Whole-exome sequencing revealed a novel nonsense variant IRF2BPL (NM_024496) Exon C.562C > T (p.Arg188*).&lt;h4>Conclusion&lt;/h4>This case report presents a Chines</pubmed_abstract><journal>BMC neurology</journal><pubmed_title>IRF2BPL gene variants with dystonia: one new Chinese case report.</pubmed_title><pmcid>PMC9862514</pmcid><funding_grant_id>20377764D</funding_grant_id><funding_grant_id>201804A011</funding_grant_id><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Zhang JT</pubmed_authors><pubmed_authors>Zhang R</pubmed_authors><pubmed_authors>Yang F</pubmed_authors><pubmed_authors>Dai Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>IRF2BPL gene variants with dystonia: one new Chinese case report.</name><description>&lt;h4>Background&lt;/h4>The carriers of damaging heterozygous variants in interferon regulatory factor 2 binding protein-like (IRF2BPL), encoding a member of the IRF2BP family of transcriptional regulators, may be affected by a variety of neurological symptoms, such as neurodevelopmental regression, language and motor developmental delay, seizures, progressive ataxia and a lack of coordination, and even dystonia.&lt;h4>Case presentation&lt;/h4>We report a Chinese boy who presented with dystonia, dysarthria, and normal development due to nonsense IRF2BPL mutation, with intact imaging and EEG findings but without developmental delays or seizures. Whole-exome sequencing revealed a novel nonsense variant IRF2BPL (NM_024496) Exon C.562C > T (p.Arg188*).&lt;h4>Conclusion&lt;/h4>This case report presents a Chines</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2026-03-18T13:45:10.922Z</modification><creation>2025-04-04T13:07:36.092Z</creation></dates><accession>S-EPMC9862514</accession><cross_references><pubmed>36670390</pubmed><doi>10.1186/s12883-023-03077-x</doi></cross_references></HashMap>